Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
来源
NEUROSCIENTIST | 2002年 / 8卷 / 05期
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [22] Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine
    Cardoso, Susana
    Carvalho, Cristina
    Correia, Sonia C.
    Seica, Raquel M.
    Moreira, Paula I.
    BRAIN PATHOLOGY, 2016, 26 (05) : 632 - 647
  • [23] Mitochondrial genomic contribution to mitochondrial dysfunction in Alzheimer's disease
    Onyango, Isaac
    Khan, Shaharyar
    Miller, Bradley
    Swerdlow, Russell
    Trimmer, Patricia
    Bennett, James, Jr.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 183 - 193
  • [24] Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder
    Fisar, Zdenek
    Hansikova, Hana
    Krizova, Jana
    Jirak, Roman
    Kitzlerova, Eva
    Zverova, Martina
    Hroudova, Jana
    Wenchich, Laszlo
    Zeman, Jiri
    Raboch, Jiri
    MITOCHONDRION, 2019, 48 : 67 - 77
  • [25] Mechanisms of Mitochondrial Dysfunction in Alzheimer's Disease
    Cadonic, Chris
    Sabbir, Mohammad Golam
    Albensi, Benedict C.
    MOLECULAR NEUROBIOLOGY, 2016, 53 (09) : 6078 - 6090
  • [26] Mitochondrial therapeutic interventions in Alzheimer's disease
    Giau, Vo Van
    An, Seong Soo A.
    Hulme, John P.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 395 : 62 - 70
  • [27] Mitochondria and Mitochondrial Cascades in Alzheimer's Disease
    Swerdlow, Russell H.
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (03) : 1403 - 1416
  • [28] Metabolomics and mitochondrial dysfunction in Alzheimer's disease
    Kim, Dong Hee
    Gim, Jeong-An
    Yoon, Dahye
    Kim, Suhkmann
    Kim, Heui-Soo
    GENES & GENOMICS, 2017, 39 (03) : 295 - 300
  • [29] The mitochondrial peptidasome PreP and Alzheimer's disease
    Glaser, Elzbieta
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2012, 1817 : S65 - S65
  • [30] Mitochondrial DNA and Inflammation in Alzheimer's Disease
    Galizzi, Giacoma
    Di Carlo, Marta
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (11) : 8586 - 8606